RxDoctor Payments Data

Taylor Braswell, PA

Physician Assistant · Pinetops, NCNPI 1376256586

Payments from drug & device makers

$1,458in general payments, 2019–2025

Across 79 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$438
  • Novo Nordisk$334
  • Novartis$127
  • Lilly USA, LLC$109
  • Pfizer$89
  • Amgen$82
  • plus $279 from 9 others

What the payments were for

  • Food & beverage$1,458100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,458 in reported general payments places this provider in the 75th percentile of 7,441 physician assistant providers in North Carolina.

See all physician assistant providers in North Carolina

Medicare billing

Part B allowed, 2024
$1,225
Medicare patients
74
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide61$70,457
JardianceEmpagliflozin83$62,452
MounjaroTirzepatide34$35,072
JanuviaSitagliptin Phosphate34$23,980
TrulicityDulaglutide22$20,794
Trelegy ElliptaFluticasone/Umeclidin/Vilanter22$15,201
RybelsusSemaglutide12$14,557
LinzessLinaclotide20$13,908
FarxigaDapagliflozin Propanediol12$12,652
Tresiba Flextouch U-200Insulin Degludec19$12,222
DexilantDexlansoprazole12$6,961
MyrbetriqMirabegron13$5,428
Stiolto RespimatTiotropium Br/Olodaterol Hcl11$5,113
PremarinEstrogens, Conjugated14$3,050
Dexlansoprazole DrDexlansoprazole11$2,963

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$334$85,01373 claims
Lilly USA, LLCMounjaro, Trulicity$109$55,86656 claims
GSKTrelegy Ellipta$14$15,20122 claims
AbbVieLinzess$41$13,90820 claims
AstraZenecaFarxiga$438$12,65212 claims
PfizerPremarin$89$3,05014 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 7,441 physician assistant providers in North Carolina.

Other physician assistant in Pinetops

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →